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        Introduction 
 Phosphoinositide-3 kinase (PI3K)/Akt signaling regulates several 
important functions in cells, such as cell cycling, apoptosis, cell 
growth, and cell migration. PI3K activity is induced by insulin 
and various growth factors such as EGF, PDGF, and insulin-like 
growth factor 1 (IGF-1). PI3K phosphorylates phosphatidylinosi-
tol 4,5-diphosphate (PIP2) to form phosphatidylinositol 3,4,5-
  triphosphate (PIP3;  Franke et al., 1995  ;   Alessi et al., 1996 ;   Dudek 
et al., 1997  ;   Okano et al., 2000  ). An oncogene,   v-PI3K ,  encoding 
a catalytic subunit (PI3Kp100    ) of PI3K plays an active role in 
oncogenic transformation (  Chang et al., 1997  ;   Aoki et al., 2000  ), 
and a tumor suppressor, PTEN, dephosphorylates PIP3 to form 
PIP2 (  Furnari et al., 1998  ). PIP3 directly as well as indirectly acti-
vates Akt, also known as protein kinase B. Activated Akt directly 
phosphorylates many cellular proteins such as p122RhoGAP, 
BAD, p27 
kip1  , glycogen synthase kinase 3     (GSK3   ), and endo-
thelial nitric oxide synthase (  Cross et al., 1995  ;   Datta et al., 1997  ; 
  Fulton et al., 1999  ;   Shin et al., 2002  ;   Hers et al., 2006  ). v-Akt, an 
oncogenic gag-fused Akt, has strong kinase activity and transfor-
mation activity in rodent and avian cells (  Staal, 1987  ;   Bellacosa 
et al., 1991  ). Akt phosphorylates serines or threonines in the mo-
tif RXRXX(S/T) (  Yaffe et al., 2001  ). Some Akt substrates bind to 
14-3-3 in a phosphorylation-dependent manner. For example, 
BAD itself enhances apoptosis, but when it is phosphorylated by 
Akt at a serine residue, 14-3-3 binds to it and releases antiapop-
totic Bcl-2 family proteins from it (  Hsu et al., 1997  ). When Akt 
phosphorylates Thr157 of p27 
kip1  , a cyclin-dependent kinase in-
hibitor, phosphorylated p27 
kip1   binds to 14-3-3, and this protein 
complex is sequestered in the cytoplasm and promotes cell 
cycling (  Sekimoto et al., 2004  ). These lines of evidence indicate 
that some Akt substrates exert their functions through association 
with 14-3-3. 
 14-3-3 is a family of proteins with seven isoforms in mam-
mals and is ubiquitously expressed. 14-3-3 forms homo- or hetero-
dimers and interacts with various cellular proteins, acting as 
an adaptor or a molecular chaperone. 14-3-3 interacts with 
its target proteins in either a phosphorylation-dependent or 
-independent manner. 14-3-3 itself has no enzymatic activity, 
although its binding to the target proteins may lead to enhanced 
apoptosis, cell cycling, cell growth, vesicular transport, cell 
spreading, or cell migration (  Mhawech, 2005  ). 14-3-3 is associ-
ated with several signaling pathways, including PI3K  –  Akt sig-
naling. It affects not only the interaction between Akt substrates 
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fected with FLAG-Kank expression vector. Then, after the 
co  precipitated proteins were separated by SDS-PAGE, the bound 
proteins were subjected to matrix-assisted laser desorption 
ionization on a time-of-fl   ight mass spectrometry (unpub-
lished data). We found several proteins that bind to Kank, 
including 14-3-3     and    .  We  fi  rst confi  rmed the interaction 
between Kank and 14-3-3 by immunoprecipitation and immuno-
staining (  Fig. 1  ). Endogenous 14-3-3     was coimmunoprecip-
itated with an anti-Kank antibody (  Fig. 1 A  , lane 2), and Kank 
and 14-3-3 were colocalized in VMRC-RCW cells (  Fig. 1 B  , 
panels 1  –  3). 
  We then examined which isoform of 14-3-3 bound to Kank 
(  Fig. 1 C  ). FLAG-tagged Kank and HA-tagged isoforms of 
14-3-3, which were expressed in HEK293T cells, were immuno-
precipitated with an anti-FLAG antibody. The results indicate 
that 14-3-3     strongly bound to Kank, whereas 14-3-3   ,  14-3-3  , 
and 14-3-3     also bound to Kank. 
  Kank binds to 14-3-3 when its 14-3-3  –
  binding motifs are phosphorylated by Akt 
  14-3-3 interacts with its target proteins in both phosphoserine/
phosphothreonine-dependent and -independent manners. Kank 
contains several candidate 14-3-3-binding motifs with potential 
phosphorylation at their serine residues. Because a construct 
of Kank with a deletion of the coiled-coil domain could not 
bind to 14-3-3 (unpublished data), we focused on two candi-
date motifs in the coiled-coil domain (149  –  156 and 162  –  169: 
  Fig. 2 A  ). We replaced serine with alanine in the candidate 
motifs (S154A and S167A) and examined the interaction be-
tween the wild type or the mutants (Kank 
S154A   and  Kank 
S167A )  of 
Kank and 14-3-3     ( Fig.  2  B ).  Kank 
S154A   still bound to 14-3-3    
(  Fig. 2 B  , lane 4), whereas Kank 
S167A   (lane 5) and a mutant 
containing both mutations (Kank 
S154A+S167A  ; lane 6) could not 
bind to 14-3-3    . Other isoforms of 14-3-3 could not bind to 
Kank 
S167A   either (unpublished data). To test whether the inter-
action between Kank and 14-3-3 was direct or indirect, we 
performed in vitro pull-down assays (  Fig. 2 C  ). All GST-fused 
14-3-3 isoforms bound to the wild-type coiled-coil domain 
(Coil) but not to Coil 
S167A . 
  The 14-3-3  –  binding motif at 164  –  169 has an Akt-phos-
phorylation motif, and the amino acid Ser167 is a candidate 
site of phosphorylation by Akt (  Fig. 2 A ). To  determine whether 
this amino acid was phoshorylated by Akt or not, we performed 
in vitro phosphorylation assays (  Fig. 2 D  ). First, GST-GSK3    
was phosphorylated by Akt, confi  rming that this Akt kinase 
activity was suffi  cient. Under this condition, GST-14b, which 
contains a 14-3-3  –  binding motif in Kank, was phosphorylated 
(  Fig. 2 D  , lane 3), but GST-14bM (  Fig. 2 D  , lane 4), which 
contains the motif with a mutation of S167A, was not phos-
phorylated. Therefore, the motif at 164  –  169 was responsible 
for binding of Kank to 14-3-3, and Ser167 was the site of 
phosphorylation by Akt. 
  Because Ser167 was a key amino acid for binding of 
14-3-3 and this serine was phosphorylated by Akt in vitro, 
there was a possibility that the binding between Kank and 
14-3-3 was phosphoserine dependent. To examine this, we 
performed in vitro pull-down assays using maltose-binding 
and 14-3-3, but also the PI3K  –  Akt pathway and its upstream 
factors. 14-3-3   binds to a catalytic subunit of PI3K (PI3Kp110) 
and inhibits its activity (  Bonnefoy-B  é  rard et al., 1995  ). 14-3-3 
binds to some proteins upstream of PI3K  –  Akt, such as insulin 
receptor substrate (IRS)-1, IGF-1 receptor, EGFR, and integrin 
    1, and regulates these signals (  Craparo et al., 1997  ;   Han et al., 
2001  ;   Oksvold et al., 2004  ). Accordingly, 14-3-3 is important 
for the regulation of these signaling pathways. 
  Cell migration plays a central role in many biological and 
pathological processes such as embryogenesis, tissue repair, 
cell invasion, and metastasis. PI3K  –  Akt signaling is also asso-
ciated with cell migration. PI3K enhances actin remodeling 
and generates membrane protrusions through activating Rac1 
(  Scita et al., 2000  ). PI3K  –  Akt signals also induce the activation 
of p70S6K, causing the remodeling of actin and leading to 
cell migration and cell invasion (  Qian et al., 2004  ). An Akt-
interacting protein, Girdin/Akt-phosphorylation enhancer (APE), 
promotes actin organization and cell motility regulated by Akt 
(  Enomoto et al., 2005  ). Because of these fi  ndings, PI3K signals 
are considered to be important in cell migration by controlling 
actin dynamics. 
 The   Kank   gene, which encodes a kidney ankyrin repeat  –
  containing protein, was originally identifi  ed in the region show-
ing a loss of heterozygosity in renal cell carcinoma (RCC); 
reduced or loss of expression of the gene was observed in RCC 
tissues and cell lines, and overexpression of Kank resulted in 
disorganization of     -actin distribution in G-402 cells (  Sarkar 
et al., 2002  ). In familial cerebral palsy, the region containing 
the   Kank   gene is often deleted, and this lesion is likely to be 
associated with this disease (  Lerer et al., 2005  ). An orthologue 
of Kank in   Caenorhabditis elegans  , VAB-19, is localized at 
the epidermal attachment structure, and a mutant of this gene 
causes a phenotype of aberrant actin organization (  Ding et al., 
2003  ). Furthermore, Kank inhibits the polymerization of actin 
and the formation of membrane ruffl  es induced by active 
Rac1/cdc42 by directly binding to IRSp53 (unpublished data). 
From these lines of evidence, Kank is likely to be important 
for actin dynamics. Kank has a coiled-coil domain at the 
N terminus and an ankyrin repeat domain at the C terminus. 
These domains may be involved in  protein – protein  interactions, 
and, as it has no apparent enzymatic domain, Kank may work 
as an adaptor protein. Therefore, identifi  cation of Kank-binding 
proteins is important to fi  nd its functions. 
  Here, we fi  nd that Kank is a substrate of Akt and binds to 
14-3-3 in a phosphoserine-dependent manner. The interaction 
between 14-3-3 and Kank is regulated by PI3K  –  Akt signaling. 
Furthermore, Kank regulates actin stress fi  bers and the migra-
tion of cells through the inhibition of RhoA, which is controlled 
by binding of Kank to 14-3-3. 
  Results 
  Kank binds to 14-3-3 isoforms     ,     ,     , and      
  To characterize the functions of Kank exerted through its 
binding proteins, we performed a pull-down assay using an 
anti  –  FLAG-tag mAb conjugated to agarose gel with the ly-
sate of human embryonic kidney (HEK) 293T cells trans-539 KANK REGULATES R  HO  A VIA 14-3-3   •   Kakinuma et al.
which reduced the activity of Akt, the association of Kank 
and 14-3-3     was signifi  cantly reduced. In contrast, when 
rapamycin, an inhibitor of mammalian target of rapamycin 
(mTOR), was used (  Fig. 3 A  , lane 5), the association of these 
proteins was not affected. Moreover, when the cells were 
stimulated with insulin or EGF, the association of these pro-
teins was signifi  cantly increased (  Fig. 3 B  , lanes 3 and 5, 
respectively). Meanwhile, when the cells pretreated with 
LY294002 were stimulated with the growth factors, the en-
hancement of the association of Kank and 14-3-3     was  not 
observed (  Fig. 3 B  , lanes 4 and 6). These fi  ndings indicate 
that the interaction of Kank and 14-3-3 may occur down-
stream of these growth factors and be controlled by PI3K  –
 Akt  signaling. 
  Kank inhibits actin stress ﬁ  bers 
through 14-3-3 
  Overexpression of Kank disorganized     -actin distribution in 
G-402 cells (  Sarkar et al., 2002  ). Because 14-3-3 also affects 
actin dynamics (  Roth et al., 1999  ;   Jin et al., 2004  ), we examined 
whether the association between Kank and 14-3-3 affected actin 
protein (MBP)-fused, phosphorylated, or unphosphorylated 
coiled-coil domains (  Fig. 2 E  ). Phosphorylation of this protein 
enhanced the binding to 14-3-3. In addition, the positions of 
the bands for both Kank and Kank 
S167A   in  polyacrylamide 
gels were shifted after the treatment with calyculin A, a pro-
tein phosphatase 2A inhibitor (unpublished data). Therefore, 
Kank may be phosphorylated at several sites, including Ser167, 
and its functions could be regulated by phosphorylation of 
these sites. 
  Association between Kank and 14-3-3 
occurs downstream of PI3K  –  Akt signaling 
and is enhanced by growth factors 
  PI3K  –  Akt signaling is activated by growth factors such as 
insulin and EGF. Because Kank was phosphorylated by Akt 
in vitro (  Fig. 2 D  , lane 3), the association of Kank and 14-3-3 
may be regulated by the PI3K  –  Akt signals initiated by these 
growth factors. To examine this possibility, we performed 
immunoprecipitation assays using PI3K inhibitors (  Fig. 3 A  ). 
When the assays included the PI3K inhibitors LY294002 
(  Fig. 3 A  , lane 3) and wortmannin (  Fig. 3 A  , lane 4), both of 
  Figure 1.       Kank interacts with 14-3-3 iso-
forms     ,     ,     , and     .   (A) Kank interacts with 
14-3-3    . VMRC-RCW cells were lysed and 
the lysate was immnunoprecipitated (IP) with 
control rabbit IgG (lane 1) or anti-Kank pAb 
(lane 2). The immunoprecipitates and the ly-
sate (lane 3) were subjected to Western blot-
ting (WB) using the antibodies indicated. 
(B) Endogenous Kank and 14-3-3 proteins are 
colocalized in VMRC-RCW cells. A ﬂ  uorescence 
image of Kank (green, lane 1), a ﬂ  uorescence 
image of 14-3-3 (red, lane 2), a merged image 
of lanes 1 and 2 (yellow, lane 3), and a light 
microscope image (lane 4) are shown. Bar, 
10   μ  m. (C) Kank associates with 14-3-3 iso-
forms     ,     ,     , and     . HEK293T cells were 
transfected with the indicated expression vec-
tors. Immnunoprecipitation was performed 
using an anti-FLAG antibody and the bound 
proteins were detected by Western blotting us-
ing the antibodies indicated.     JCB • VOLUME 181 • NUMBER 3 • 2008  540
  Kank inhibits insulin-stimulated cell 
migration through 14-3-3 
  Cell migration plays a central role in many biological and path-
ological processes such as embryogenesis, tissue repair, tumor 
invasion, and metastasis. When cells are moving, the lamellipo-
dial and fi  lopodial membrane protrusions are formed at the 
leading edge after the activation of Rac1 or cdc42. PI3K and 
PTEN are polarized in migrating cells and PI3K is accumulated 
at the leading edge of the cells (  Ridley et al., 2003  ). Girdin/APE 
and p70S6K, downstream effectors in PI3K – Akt signaling, regu-
late cell migration (  Qian et al., 2004  ;   Enomoto et al., 2005  ). 
Rather, 14-3-3 enhances cell migration (  Rodriguez and Guan, 
2005  ). Because the function of Kank through 14-3-3 is likely 
to be exerted downstream of PI3K  –  Akt and may affect actin or-
ganization, Kank may inhibit cell migration. To examine this, 
we performed cell migration assays (  Figs. 5   and S2 B, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200707022/DC1). 
We generated HEK293 cells expressing FLAG-Kank or 
dynamics. Immunofl  uorescence staining was performed using 
the cells overexpressing Kank or Kank mutants in the presence 
or absence of 14-3-3     ( Fig.  4 ).  When  Kank  was  overexpressed, 
the number of cells with clear actin stress fi  bers was signifi  -
cantly decreased. Kank 
   coil , a mutant with a deletion in the coiled-
coil domain, had little effect on actin stress fi  bers (  Fig. 4 A  ; 
quantifi  ed in   Figs. 4 B   and S1 A, available at http://www.jcb.org/
cgi/content/full/jcb.200707022/DC1). Expression of Kank 
S167A , 
which lacked the ability to bind to 14-3-3, slightly decreased the 
number of cells with higher levels of actin stress fi  bers (  Fig. 4 B  , 
lane 4), but the number was higher than that with Kank ex-
pression (  Fig. 4 B  , lane 2). The inhibitory effect of Kank on the 
formation of actin stress fi  bers was eliminated by the coexpression 
of 14-3-3     (  Fig. 4 B  , lane 6). Furthermore, knockdown of Kank 
enhanced F-actin in NIH3T3 cells (Fig. S1 B). Based on these 
fi  ndings, we hypothesized that Kank inhibits the formation of 
actin stress fi  bers and that one of the potential mechanisms is 
the interaction between Kank and 14-3-3   . 
  Figure 2.       The 14-3-3  –  binding motif of Kank 
is phosphorylated by Akt in vitro and their 
interaction is phosphorylation dependent.   
(A) The amino acid sequences of candidate 
14-3-3  –  binding (149  –  156 and 162  –  169) 
and Akt-phosphorylation (162  –  167) motifs. 
The consensus sequences of the 14-3-3  –  bind-
ing motif and the Akt-phosphorylation mo-
tif are also shown. (B) Binding of 14-3-3 to 
wild-type or mutant Kank. Either Ser154 or 
Ser167, or both, in Kank were replaced by 
Ala. HEK293T cells expressing wild-type Kank 
(WT, lanes 2 and 3) or Kank containing muta-
tions (S154A, S167A, and S154A + S167A; 
lanes 4, 5, and 6, respectively) were subjected 
to immunoprecipitation followed by Western 
blotting using the indicated antibodies. (C) 
The interaction between Kank and 14-3-3 is 
direct and requires Ser167. GST-fused 14-3-3 
isoforms expressed in bacteria were pulled 
down using the in vitro translated coiled-coil 
domain (Coil; amino acids 90  –  360) of Kank 
or its mutant containing S167A (Coil 
S167A  ). 
Coprecipitates were subjected to Western blot-
ting and detected by staining with streptavidin-
HRP. (D) Ser167 of Kank is phosphorylated 
by Akt in vitro. GST-14b (amino acids 
161  –  171 of Kank, lane 3) and GST-14bM 
(amino acids 161  –  171 of Kank containing a 
mutation of S167A, lane 4), GST, a negative 
control (lane 1), and GST-GSK3    , a positive 
control (lane 2), which were all expressed in 
bacteria, were subjected to phosphorylation by 
Akt. The samples before (  	  Akt) or after (+Akt) 
treatment with Akt along with Coomassie 
staining are shown. (E) Phosphorylation of the 
14-3-3  –  binding motif by Akt enhances the asso-
ciation of Kank with 14-3-3. MBP-Coil with (+) 
or without (  	  ) phosphorylation was subjected 
to pull-down assays with GST 14-3-3 isoforms 
    ,     ,     , or      or control GST and the bound 
MBP-tagged protein was detected using an 
anti-MBP antibody.     541 KANK REGULATES R  HO  A VIA 14-3-3   •   Kakinuma et al.
RhoA, RhoA 
G14V  , enhances the formation of actin stress fi  bers 
and vinculin-containing focal adhesions (  Nobes and Hall, 1995 ). 
RhoA also controls cell motility and cell invasion (  Takaishi 
et al., 1993  ;   Yoshioka et al., 1999  ;   Kurokawa and Matsuda, 2005  ). 
When cells are moving, RhoA activates migrating cells not only 
at the tail but also at the leading part. Because Kank inhibits ac-
tin stress fi  bers and cell migration, we examined whether Kank 
inhibits RhoA activity by pull-down assays using a GST-fused 
RhoA-binding domain (RBD) of rhotekin (GST-RBD;   Fig. 6  ). 
When Kank was expressed, the amount of active RhoA was sig-
nifi  cantly reduced ( Fig. 6 A , lane 3). In contrast, when Kank 
S167A , 
which is unable to bind to 14-3-3, was expressed, the amount of 
active RhoA was not markedly affected ( Fig. 6 A , lane 4). Further-
more, knockdown of Kank signifi  cantly increased the amount 
of active RhoA (  Fig. 6 A  , lane 2). When 14-3-3     was expressed, 
the amount of active RhoA was slightly increased (  Fig. 6 B  , 
lane 2). Moreover, coexpression of 14-3-3     with  Kank abolished 
the effect of Kank, and the level of active RhoA was decreased 
(  Fig. 6 B  , lane 3). We generated stable NIH3T3 cell lines ex-
pressing tetracycline-inducible GFP-Kank or GFP-Kank 
S167A  
and used them to study the role of Kank in active RhoA (  Fig. 6, 
C and D  ). When GFP-Kank was expressed, the amount of active 
RhoA was signifi  cantly reduced (  Fig. 6, C and D  , lanes 1 and 3), 
whereas the expression of GFP-Kank 
S167A   had little effect on 
the amount of active RhoA (  Fig. 6, C and D  , lanes 5 and 7), 
as was observed with the transient expression of Kank or its 
mutant (  Fig. 6 A  ). 
  Insulin activates RhoA in rat adipocytes (  Karnam et al., 
1997  ). Here, we also observed that insulin increased the amount 
of active RhoA (  Fig. 6, C and D  ). The expression of GFP-Kank 
signifi  cantly inhibited the increase of active RhoA stimulated 
FLAG-Kank 
S167A   using tetracycline-inducible HEK293 cells, 
TREx-293 cells, in which the expression of these genes can be 
induced with tetracycline (  Fig. 5 C  ). The expression of Kank 
inhibited cell migration, although Kank 
S167A   had little effect on 
cell migration (  Fig. 5, A and B  ). Kank transiently expressed in 
HEK293 cells also inhibited cell migration, whereas Kank 
S167A  
had little effect on cell migration (Fig. S2 B, 2 and 3, white col-
umns). Furthermore, the Kank knockdown cells using endo-
ribonuclease-prepared siRNA (esiRNA) in which little endogenous 
Kank protein was expressed (  Fig. 5 E  , lane 2) showed up-
regulation of cell migration (  Fig. 5 D  , lane 2). Because Shanley 
et al. (  2004  ) found that insulin induces cell migration in the cor-
neal epithelium, we examined whether Kank inhibits insulin-
dependent cell migration in TREx-293 cells (  Fig. 5  ). Insulin 
enhanced cell migration about twofold, and insulin-stimulated 
cell migration was signifi  cantly reduced upon the expression of 
Kank (  Fig. 5 A  , lane 4). However, Kank 
S167A   did not show any 
inhibitory effect on insulin-induced cell migration (  Fig. 5 B  , 
lane 4). Kank and Kank 
S167A   transiently expressed in HEK293 
cells also showed a similar tendency (Fig. S2 B, black columns). 
Furthermore, knockdown of Kank slightly enhanced insulin-
induced cell migration (  Fig. 5 D  , lane 4). In contrast, coexpression 
of 14-3-3     with Kank abolished this effect (Fig. S2 A). These 
results suggest that Kank inhibits insulin-induced cell migration 
through 14-3-3. 
  Kank inhibits insulin-induced RhoA 
activation through 14-3-3 
  Actin stress fi  bers are one of the major cytoskeletal structures, 
and GTP-loaded RhoA stimulates actin stress fi  bers in response 
to growth factors (  Ridley and Hall, 1992  ). An active form of 
  Figure 3.       The interaction between 14-3-3 and 
Kank occurs downstream of PI3K  –  Akt signal-
ing and is enhanced by growth factors.   (A) The 
association between 14-3-3 and Kank occurs 
downstream of the PI3K  –  Akt signaling. After 
IMCD cells were treated with vehicle (DMSO, 
lanes 1 and 2), 50   μ  M LY294002 (lane 3), 
100 nM wortmannin (lane 4), or 0.2 nM 
rapamycin (lane 5) for 24 h, the cells were 
collected, lysed, and subjected to immuno-
precipitation using anti  –  mouse Kank antibody. 
The results of Western blotting are shown on 
the left and the intensities of the bands quanti-
ﬁ  ed using an ImageQuant image analyzer are 
shown on the right. *, P   <   0.01 compared 
with the vehicle; **, P   <   0.05 compared with 
the vehicle. (B) The interaction between 14-3-3 
and Kank is enhanced by insulin and EGF. 
IMCD cells either pretreated (lanes 4 and 6) 
or not pretreated (lanes 3 and 5) with 50   μ  M 
LY294002 (LY) were treated with 10   μ  g/ml in-
sulin (lanes 3 and 4) or 10 ng/ml EGF (lanes 
5 and 6). The experiments were performed as 
described in A. *, P   <   0.01 compared with 
the control; **, P   <   0.05 compared with the 
control. The results shown are the mean   ±   SD 
of at least triplicate experiments.     JCB • VOLUME 181 • NUMBER 3 • 2008  542
  Figure 4.       Kank inhibits the formation of actin 
stress ﬁ  bers through 14-3-3.   (A) Kank inhibits 
the formation of actin stress ﬁ  bers. Kank or its 
mutants (Kank 
    coil  -FLAG, Kank with deletion of 
amino acids 90  –  360, and Kank 
S167A  -FLAG) 
were expressed with or without 14-3-3     in 
NIH3T3 cells. The cells were incubated with 
an anti-Kank pAb or anti-Kank mAb together 
with an anti-GFP antibody. Kank protein was 
detected using Alexa Fluor 488  –  conjugated 
goat anti  –  rabbit IgG (green, top middle) or 
Cy5-conjugated goat anti  –  mouse antibody 
(purple, bottom middle). GFP protein was de-
tected using Alexa Fluor 488  –  conjugated goat 
anti  –  rabbit IgG (green, left). F-actin was stained 
with TRITC-conjugated phalloidin. Arrowheads 
indicate the cells expressing the transfected 
vectors. Bar, 10   μ  m. (B) The number of the cells 
with actin stress ﬁ   bers was quantiﬁ  ed.  Kank 
and its mutants were transiently expressed and 
the cells were stained as described in A. 100 
cells expressing the transfected genes were ex-
amined and the results shown are the means   ±   
SD of three independent experiments. *, P   <   
0.01 compared with the control; **, P   <   0.05 
compared with the control.     543 KANK REGULATES R  HO  A VIA 14-3-3   •   Kakinuma et al.
but GTP loading of RhoA was not inhibited by wortmannin 
( Karnam  et  al., 1997  ). Here, we investigated whether or not the 
amount of active RhoA is increased through PI3K  –  Akt signal-
ing after stimulation with insulin in NIH3T3 cells (  Fig. 6 H  ). 
When NIH3T3 cells were pretreated with LY294002, the level 
of active RhoA was signifi  cantly decreased (unpublished data). 
Furthermore, constitutively active Akt increased the level of ac-
tive RhoA (  Fig. 6, H and I  , lane 2). We also assessed active 
RhoA levels in the cells in which Kank and Kank 
S167A   were  co-
expressed with constitutively active Akt. The overexpression of 
Kank signifi  cantly inhibited active Akt-dependent RhoA acti-
vation, whereas Kank 
S167A   had little effect (  Figs. 6, H and I  , 
lanes 3 and 4). 
  Kank regulates cell migration by inhibition 
of RhoA activity 
  C3 transferase is an ADP-ribosyltransferase of   Clostridium bot-
ulinum   specifi  c to Rho that affects both actin stress fi  bers and 
cell morphology and inhibits cell motility (  Paterson et al., 1990  ; 
by insulin (  Fig. 6, C and D,   lanes 2 and 4), whereas GFP-
Kank 
S167A   had little effect on the level of active RhoA (  Fig. 6, 
C and D  , lanes 6 and 8). We established stable NIH3T3 cells in 
which knockdown of Kank was induced with tetracycline and 
the amount of Kank was reduced by     70% (  Fig. 6, E and G  , 
lanes 3 and 4). Using this cell line, we performed GST-RBD 
pull-down assays for the detection of active RhoA. In the cells 
in which Kank was knocked down, the amount of active RhoA 
was signifi  cantly increased, as shown in   Fig. 6 (A, lane 2; and 
Fig. 6, E and F,   lane 3), whereas the level of active RhoA did not 
show signifi  cant differences between the control and knock-
down cells when the cells were stimulated with insulin (  Fig. 6, 
E and F  , lanes 2 and 4). 
  Meanwhile, PI3K signals may be related to RhoA activa-
tion. Qiang et al. (  2004  ) showed an IGF-1  –  induced GTP-RhoA 
increase in myeloma cells, and this induction was inhibited by 
LY294002 (  Qiang et al., 2004  ). However, Karnam et al. (  1997  ) 
showed that RhoA was translocated to the membrane through 
PI3K signaling after insulin stimulation in rat adipocytes, 
  Figure 5.       Kank inhibits cell migration through 
14-3-3 and partially inhibits insulin-mediated 
cell migration.   (A and B) Tetracycline-inducible 
TREx-293 cells stably expressing Kank (A) or 
Kank 
S167A   (B) were subjected to cell migration 
assays using TransWell. TREx-293 cells ex-
pressing tetracycline-inducible FLAG-Kank or 
FLAG-Kank 
S167A   with (lanes 3 and 4) or without 
(lanes 1 and 2) insulin (10   μ  g/ml) stimulation 
were used for cell migration assays. The ratios 
of migration compared with the control were 
calculated. The results shown are the means   ±   
SD of triplicate experiments. Tet, tetracycline 
induction. *, P   <   0.01 compared with the con-
trol ; **, P   <   0.05 compared with the control. 
(C) The expression of FLAG-Kank and FLAG-
Kank 
S167A   is induced in tetracycline-inducible 
TREx-293 cells. The expression of FLAG-Kank 
(lanes 1  –  4) and FLAG-Kank 
S167A   (lanes 5  –  8) 
with or without the treatment with 10   μ  g/ml 
insulin and/or tetracycline was examined by 
Western blotting. (D) Knockdown of Kank en-
hances cell migration. The esiRNA of Kank 
(Kank KD, lanes 2 and 4) and control esiRNA 
(lanes 1 and 3) were prepared as described 
in Materials and methods and transfected into 
HEK293 cells. Cell migration assays were 
performed using these transfected cells in the 
presence (lanes 3 and 4) or absence (lanes 1 
and 2) of 10   μ  g/ml insulin. The relative mi-
gration was calculated as described in A. 
*, P   <   0.01 compared with the control; ***, P   <   
0.01 compared with the control and P   <   0.05 
compared with Kank KD. (E) The expression of 
endogenous Kank is decreased by the esiRNA 
of Kank. The expression levels of endogenous 
Kank were determined by Western blotting. 
The cells were transfected and stimulated as 
described in D.     JCB • VOLUME 181 • NUMBER 3 • 2008  544
  Figure 6.       Kank inhibits PI3K  –  Akt  –  dependent activation of RhoA through 14-3-3.   (A) Kank inhibits active RhoA through 14-3-3. RNAi for knockdown of 
Kank (Kank-RNAi, lane 2), Kank-FLAG (lane 3), or Kank 
S167A  -FLAG (lane 4) was transfected in NIH3T3 cells, and GST-RBD pull-down assays were per-
formed to determine the expression levels of active RhoA (GTP-RhoA). The amounts of active RhoA in Western blot data were quantiﬁ  ed, and the amounts 
relative to that of the control (lane 1) are shown below the GTP-RhoA data. (B) Overexpression of 14-3-3     blocks Kank function in RhoA activation. After 
electroporation as indicated in NIH3T3 cells, a GST-RBD pull-down assay was performed to quantify the amount of active RhoA (GTP-RhoA). The amounts 
of active RhoA in Western blot data were quantiﬁ  ed and the amounts relative to that of the control (lane 1) are shown below the GTP-RhoA data. The results 
shown are the mean   ±   SD of triplicate experiments. *, P   <   0.01 compared with the control. (C and D) GFP-Kank but not GFP-Kank 
S167A   inhibits insulin-dependent 
RhoA activation. We generated tetracycline-inducible stable cells expressing GFP-Kank (lanes 1  –  4) or GFP-Kank 
S167A   (lanes 5  –  8) using NIH3T3 cells and tested 
the levels of active RhoA in these cells with (lanes 2, 4, 6, and 8) or without (lanes 1, 3, 5, and 7) insulin stimulation. Western blotting results are shown in C. 
The levels of active RhoA, shown in C, were quantiﬁ  ed, and the relative levels of active RhoA compared with the control (lane 1) are shown in D. The results 
shown are the mean   ±   SD of triplicate experiments. *, P   <   0.01 compared with the control; **, P   <   0.05 compared with the control; ***, P   <   0.05 compared 
with the control stimulated with insulin. (E and F) Knockdown of Kank signiﬁ  cantly enhances the level of active RhoA. We generated a tetracycline-induc-
ible RNAi cell line derived from NIH3T3 cells for knockdown of Kank and performed GST-RBD pull-down assays. Western blotting results are shown in E. 
The levels of active RhoA, shown in E, were quantiﬁ  ed as described in D and are shown in F. *, P   <   0.01 compared with the control; **, P   <   0.05 545 KANK REGULATES R  HO  A VIA 14-3-3   •   Kakinuma et al.
phosphorylation of Kank in vitro by Akt (  Fig. 2 E  ). Furthermore, 
PI3K inhibitors, LY294002 and wortmannin, signifi  cantly re-
duced the level of this interaction, whereas the stimulation of 
cells with insulin and EGF signifi  cantly enhanced it (  Fig. 3, 
A and B  ). These lines of evidence suggest that PI3K  –  Akt signaling 
may control the function of Kank through 14-3-3 by phosphory-
lation of a site within the 14-3-3 – binding motif. Lack of phosphory-
lation of the 14-3-3 – binding motif and endogenous Kank resulting 
from treatment with LY294002 resulted in weak binding of 
Kank to 14-3-3 in vitro and in vivo (  Fig. 2, C and E; and Fig. 3, 
A and B  ). Raf-1 binds to 14-3-3 in a phosphorylation-dependent 
manner (  Muslin et al., 1996  ). Although recombinant bacterial 
Raf-1, which is likely to be unphosphorylated, also binds to 
14-3-3 (  Li et al., 1995  ), the complex may not be functional. 
Similarly, the interaction between the unphosphorylated 14-3-3  –
  binding motif in Kank and 14-3-3 may be nonfunctional or may 
be so weak at this interaction that Kank is not fully functional 
through 14-3-3. However, Kank bound to all isoforms of 14-3-3 
in vitro, whereas Kank bound to the isoforms    ,    ,    ,  and     
in vivo (  Figs. 1 C and 2 C  ). This difference may be caused by 
the state of folding of Kank in live cells. In fact, HSP70 is one of 
the Kank-binding proteins (unpublished data). This protein, as 
well as 14-3-3, may act as a molecular chaperone and may af-
fect the folding of Kank. The folding of Kank may be one of the 
important factors for the interaction between Kank and 14-3-3, 
and the difference of the abilities of the isoforms of 14-3-3 to 
bind to Kank may result in different functions. 
  RhoA, a small GTPase, is critical for the formation of 
actin stress fi  bers and cell migration (  Ridley and Hall, 1992  ; 
 Takaishi et al., 1993 ;  Nobes and Hall, 1995 ;  Yoshioka et al., 1999 ; 
  Kurokawa and Matsuda, 2005  ). Active RhoA, GTP-loaded 
RhoA, activates downstream effectors ROCK and Dia, resulting 
in organization of the actin cytoskeleton (  Maekawa et al., 1999  ; 
  Fukata et al., 2001  ;   Wallar and Alberts, 2003  ). RhoA is activated 
in the tail and the leading edge of migrating cells (Kurokawa 
and Matsuda, 2005), and the degree of cell invasion is signifi  -
cantly reduced when the cells are treated with a RhoA inhibitor, 
C3 transferase (  Yoshioka et al., 1999  ). These facts indicate that 
RhoA activation is tightly related to cell migration. However, 
the relationship between 14-3-3 and actin polymerization has 
not been thoroughly investigated. However, 14-3-3 enhanced 
actin cytoskeleton formation in  Saccharomyces cerevisiae  ( Roth 
et al., 1999  ;   Lottersberger et al., 2006  ). 14-3-3 has many bind-
ing partners, including those related to actin polymerization 
( Jin  et  al., 2004  ;   Pozuelo Rubio et al., 2004  ). Among them, 
p190RhoGEF and AKAP-Lbc, which are both activators of 
RhoA, were identifi  ed as 14-3-3  –  binding partners (  Zhai et al., 
2001  ;   Diviani et al., 2004  ). Furthermore, cofi  lin, an actin de-
polymerization factor, and SSH1L, a cofi  lin phosphatase, both 
  Takaishi et al., 1993  ). Rho activates Rho-associated kinase 
(ROCK), and ROCK is inhibited by a specifi  c inhibitor, Y-27632 
(  Amano et al., 2000  ). The Rho  –  ROCK signaling pathway is in-
volved in organization of the actin cytoskeleton and cell migra-
tion (  Itoh et al., 1999  ;   Amano et al., 2000  ;   Worthylake and 
Burridge, 2003  ). Knockdown of   Kank   resulted in enhanced cell 
migration (  Fig. 5 D  ). If this effect depends on the activation 
of RhoA, it should be inhibited by C3 transferase and Y-27632. 
To examine this, we performed cell migration assays using stable 
HeLa cells expressing human   Kank   RNAi  ( Fig.  7 ).  When  the 
cells were treated with cell-permeable C3 transferase, which 
can be transported through the plasma membrane, the level of 
active RhoA was signifi  cantly reduced in both the control and 
knockdown cells (  Fig. 7, A and B  , lanes 2 and 4). The migration 
of cells was slightly reduced in the control cells by the treatment 
with cell-permeable C3 transferase and Y-27632 (  Fig. 7 C  , lane 1). 
In contrast, the migration of cells was markedly reduced in 
Kank knockdown cells by the treatment with cell-permeable C3 
transferase or Y-27632 (  Fig. 7 C  , respective columns in lane 3). 
The migration of cells was inhibited for both control and Kank 
knockdown cells when they were treated with cell-permeable 
C3 transferase or Y-27632 after stimulation with insulin ( Fig. 7 C , 
respective columns in lanes 2 and 4). The cells transiently ex-
pressing   Kank   RNAi (Kank KD) showed a similar tendency in 
HEK293 cells (Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200707022/DC1). These fi  ndings suggest that 
Kank inhibits cell migration through the regulation of RhoA 
signaling. Moreover, Kank 
S167A   did not affect RhoA activity and 
cell migration (  Figs. 5 B, 6  , and S2 B), which suggests that 
Kank regulates cell migration through RhoA signaling medi-
ated by 14-3-3 binding. 
  Discussion 
  PI3K  –  Akt signaling regulates multiple biological processes 
such as cell cycling, apoptosis, cell growth, and cell migration. 
This signaling is activated by insulin and various growth factors, 
such as EGF, PDGF, and IGF-1, and the phosphorylation of Akt 
substrates is involved in some of these cellular functions ( Franke 
et al., 1995  ;   Alessi et al., 1996  ;   Dudek et al., 1997  ;   Okano et al., 
2000  ). We show here that Kank was also phosphorylated by Akt 
in vitro (  Fig. 2 D  ) and that the apparent molecular weights of Kank 
and Kank 
S167A   were altered by treatment with a protein phospha-
tase 2A inhibitor, calyculin A (unpublished data). These results 
indicate that Kank is phosphorylated not only within its 14-3-3 
binding motif but also at other serines and/or threonines, and 
this phosphorylation may be regulated by protein phosphatase 
2A and other serine/thereonine kinases. We found that Kank 
bound to 14-3-3 and that this interaction was enhanced by the 
compared with the control. (G) The level of endogenous Kank is decreased by the induction of Kank RNAi in NIH3T3 cells. The levels of endogenous Kank, 
shown in E, were quantiﬁ  ed, and the relative levels of Kank compared with the control (lane 1) were calculated. (H and I) Active Akt increases the level of 
active RhoA, whereas Kank inhibits this activation. Plasmids expressing active Akt and Kank (lane 3), Kank 
S167A   (lane 4), or active Akt alone (lane 2) were 
electroporated into NIH3T3 cells as indicated, and GST-RBD pull-down assays were performed to examine the levels of active RhoA. The results of Western 
blotting are shown in H. The levels of active RhoA, shown in H, were quantiﬁ  ed as described in D and shown in I. *, P   <   0.01 compared with the control; 
**, P   <   0.05 compared with the control; ***, P   <   0.01 compared with the control and P   <   0.05 compared with the active Akt alone.     
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the active 14-3-3 complex. As a result, the amount of active 
RhoA is decreased and the cells can negatively regulate their 
migration by decelerating the formation of actin stress fi  bers. 
This scheme would be effective when there are excess signals 
from Akt to RhoA. Furthermore, because Kank 
   coil ,  which  lacked 
a coiled-coil domain containing an IRSp53-binding site and a 
14-3-3  –  binding motif, had no effect on actin stress fi  bers (  Fig. 4  ), 
Kank function on actin stress fi  ber disorganization was not only 
dependent on 14-3-3 binding but also dependent on other proteins, 
and it is likely that there are additional mechanisms on actin 
stress fi  ber disorganization. Because the interaction between 
Kank and 14-3-3 did not affect the interaction between Kank 
and IRSp53 (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200707022/DC1), Kank function through 14-3-3 is dif-
ferent from Kank-IRSp53 function. At least, the Kank coiled-
coil domain may be important to actin stress fi  ber regulation. 
  In conclusion, Kank is a novel Akt substrate and its in-
teraction with 14-3-3 is controlled by the PI3K  –  Akt signal. 
This interaction regulates the activation of RhoA and inhibits 
the formation of actin stress fi  bers and cell migration. Kank 
is likely to be a protein negatively mediating the signal from 
bind to 14-3-3, and this interaction inhibits cofi  lin activity and 
enhances actin polymerization (  Gohla and Bokoch, 2002  ; 
  Birkenfeld et al., 2003  ;   Soosairajah et al., 2005  ). Therefore, 
14-3-3 may be important for the regulation of actin poly-
merization and the function of RhoA. We found that Kank in-
hibited RhoA activation and that this effect is caused by the 
interaction between Kank and 14-3-3, which is controlled by 
PI3K  –  Akt signaling (  Figs. 6 and 7  ). When the cells are stimu-
lated by growth factors, PI3K  –  Akt signaling also activates RhoA 
(  Qian et al., 2004  ). Simultaneously, the interaction between 
Kank and 14-3-3 may be enhanced by growth factors (  Fig. 3  ) 
and may result in the inactivation of RhoA (  Fig. 6, H and I  ). 
Moreover, cell migration may be regulated by the interaction 
between Kank and 14-3-3 through RhoA inhibition (  Figs. 5, 6, 7  , 
S2, and S3).   Fig. 8   shows a hypothetical model of Kank function 
in RhoA regulation. Stimulation by growth factors such as 
insulin activates the PI3K  –  Akt signal. The 14-3-3 complex, 
downstream of Akt or, alternatively, of other signaling path-
ways, activates RhoA. When cells need to negatively regulate 
the migration or change the direction of their migration, Akt 
phosphorylates Kank at S167, and Kank sequesters 14-3-3 from 
  Figure 7.       Knockdown of Kank enhances RhoA-dependent 
cell migration.   (A and B) HeLa cells with stable knockdown of 
Kank (Kank KD) show increased activation of RhoA, whereas 
this activation is signiﬁ  cantly blocked by cell-permeable C3 
transferase. Stable Kank KD or control cells were treated with 
1   μ  g/ml of cell-permeable C3 transferase and analyzed by 
GST-RBD pull-down assays. The levels of active RhoA were 
quantiﬁ  ed and the relative levels compared with the control 
(lane 1) are shown in B. The results shown are the means   ±   
SD of triplicate experiments. *, P   <   0.01 compared with 
the control; ***, P   <   0.01 compared with the control and 
the stable Kank KD. (C) Cell migration induced by 10   μ  g/ml 
insulin or Kank KD is inhibited by 2.5   μ  g/ml of cell-permeable 
C3 transferase and 10   μ  M Y-27632. The cells were treated 
as indicated and the cell migration assay was performed as 
described in   Fig. 5  . The results shown are the means   ±   SD of 
triplicate experiments. *, P   <   0.01 compared with the control; 
***, P   <   0.01 compared as indicated.     547 KANK REGULATES R  HO  A VIA 14-3-3   •   Kakinuma et al.
by transfecting a pcDNA6/TR vector and a pSUPERIOR.zeosin vector con-
taining a mouse sequence for knockdown of Kank as described below into 
NIH3T3 cells using an electroporation method. The pSUPERIOR.zeocin 
vector was generated from pSUPERIOR.neo+gfp (Oligoengine) by replac-
ing the   neo-GFP   fusion gene with a   zeocin  -resistance gene. All tetracycline-
inducible cell lines were cultured in media containing 150   μ  g/ml zeocin 
(Invitrogen) and 10   μ  g/ml blasticidin HCl (Invitrogen) and subjected to 
selection for 1 wk. The expression levels of Kank in the colonies after selec-
tion were checked by Western blotting. The stable Kank knockdown HeLa 
cell lines were generated by transfecting 15   μ  g of linearized pSUPER.neo 
vector containing a human sequence for knockdown of Kank as described 
below into HeLa cells using Gene Pulser II (Bio-Rad Laboratories) under 
conditions of 260 mV and 960   μ  F capacitance. After transfection, the cells 
were cultured in medium containing 500   μ  g/ml geneticin (Invitrogen) for 
2 wk and clones were selected. Endogenous expression levels of Kank were 
checked by Western blotting. 
  Cell cultures 
  HEK293T, NIH3T3, and HeLa cells were cultured in DME. Renal carci-
noma VMRC-RCW cells were cultured in MEM. HEK293 cells (provided by 
M. Noguchi, Hokkaido University, Sapporo, Hokkaido, Japan) were cul-
tured in DME (high glucose). Mouse inner medullary collecting duct (IMCD) 
cells were cultured in DME/F-12 (1:1). All media used here, except when 
the cells were subjected to serum starvation, were supplemented with 10% 
FBS and streptomycin-kanamycin (Invitrogen). All cells were cultured at 
37  °  C under a humidiﬁ  ed atmosphere of 95% air and 5% CO  2  . 
  Antibodies and reagents 
  Control rabbit IgG and control mouse IgG were obtained from Invitrogen 
and Santa Cruz Biotechnology, Inc., respectively. Anti-FLAG M2 mAb, 
anti  –      -actin mAb, AP-conjugated goat anti  –  rabbit IgG, and insulin were 
obtained from Sigma-Aldrich. Anti-HA 12CA5 mAb, anti-MBP antisera, 
and anti-His mAb were obtained from Roche, New England Biolabs, Inc., 
and QIAGEN, respectively. Anti-AFP 3E6 mAb (Qbiogene) was used for 
immunoprecipitation of GFP fusion proteins and anti-GFP antiserum (Invitro-
gen) was used for Western blotting and immunoﬂ  uorescence of GFP fusion 
proteins. The anti  –  human Kank mAb and polyclonal antibody (pAb) were 
described previously (  Roy et al., 2005  ;   Sarkar et al., 2002  ). The anti  –
  mouse Kank pAb recognized amino acids 861  –  975. 14-3-3     mAb and 
14-3-3pan pAb were obtained from Exalpha Biologicals, Inc., and Delta 
Biolabs LLC, respectively. Anti-GST 26H1 mAb, anti  –  phosho-Akt pAb, anti-
Akt pAb, anti  –  phospho-p70S6K pAb, anti-p70S6K pAb, HRP-linked goat 
anti  –  rabbit IgG, HRP-linked goat anti  –  mouse IgG, and AP-conjugated goat 
anti  –  mouse IgG were obtained from Cell Signaling Technology. Alexa 
Fluor 488 goat anti  –  rabbit IgG, Alexa Fluor 488 goat anti  –  mouse IgG, 
and Alexa Fluor 596 goat anti  –  rabbit IgG were obtained from Invitrogen. 
Cy5-conjugated goat anti  –  mouse IgG was obtained from Millipore. Calyc-
ulin A and wortmannin were purchased from BIOMOL International, 
L.P. EGF and ECL cell attachment matrix were obtained from Millipore. 
LY294002, rapamycin, and Y-27632 were obtained from EMD. HRP-
conjugated streptavidin was obtained from Invitrogen. 
  Knockdown of Kank 
  An H1 promoter-based mammalian expression vector, pSUPER.neo (Oligo-
engine), was used for transient and stable expression of siRNA in NIH3T3 
PI3K  –  Akt to RhoA. However, the mechanism of activating 
RhoA by the PI3K  –  Akt signal has not been well investigated, 
and we do not know which RhoGEF or RhoGAP is function-
ally associated with Kank. Akt and p70S6K phosphorylate 
p122RhoGAP S322 (  Hers et al., 2006  ).   Hers et al. (2006)   
speculated that this phosphorylation inhibits RhoGAP activity 
and that the amount of active RhoA is increased. This Akt 
phosphorylation motif includes a candidate 14-3-3  –  binding 
motif. Therefore, there is a possibility that p122RhoGAP is 
one of the targets of Kank in the downstream of Akt. In fact, 
Kank binds to DLC1, a tumor suppressor and a human homo-
logue of p122RhoGAP (unpublished data). However, Kank 
S167A  
also binds to DLC1 (unpublished data), and the relationship 
between Kank and DLC1 through 14-3-3 has not been exam-
ined yet. Meanwhile, the expression of Kank is reduced or 
abrogated in RCC tissues and cell lines (  Sarkar et al., 2002  ). 
As knockdown of Kank resulted in enhanced cell migration 
(  Figs. 5 D, 7 C  , and S3), this effect may be related to cancer 
progression. In addition, the deletion of the   Kank   region  at 
9p24 seems to be associated with familial cerebral palsy (  Lerer 
et al., 2005  ). Therefore, Kank might be one of the targets for 
drug discovery for treatment of these diseases. 
  Materials and methods 
  Mammalian expression plasmids and stable cells 
  To generate FLAG-tagged Kank expression plasmids, the PCR products of 
Kank cDNA (GenBank/EMBL/DDBJ under accession No.   NM_153186  ) 
were cloned into the EcoRI and SalI sites of pCMV-Tag2B (Stratagene), in 
which the FLAG tag was fused to the N terminus, or pCMV-Tag4A (Strata-
gene), in which the FLAG tag was fused to the C terminus. Point mutants 
and deletion mutants of Kank were generated by PCR. An expression plas-
mid of GFP-tagged human Kank or its mutants was generated by inserting 
the PCR products into pEGFP-C2 (Clontech Laboratories, Inc.). HA-tagged 
pcDNA3.1 was generated by inserting a short HA tag sequence into the 
NheI  –  EcoRI sites of the pcDNA3.1 vector (Invitrogen). 14-3-3 isoforms 
were cloned by RT-PCR using human kidney mRNA. HA-and GFP-tagged 
14-3-3s were generated by subcloning each isoform into an HA-tagged 
pcDNA3.1 vector and a pEGFP-C2 vector, respectively. Active Akt was 
provided by T. Nakano and T. Kimura (Osaka University, Suita, Osaka, 
Japan;   Watanabe et al., 2006  ). All plasmids were veriﬁ  ed by sequencing. 
  The tetracycline-inducible stable HEK293 cells were generated 
by transfecting a pcDNA4/TO vector containing FLAG-Kank or FLAG-
Kank 
S176A   into TREx-293 cells (Invitrogen). Tetracycline-inducible stable 
NIH3T3 cells were generated by transfecting a pcDNA6/TR vector (Invitro-
gen) and a pcDNA4/TO vector containing GFP-Kank or GFP-Kank 
S167A   
into NIH3T3 cells. Tetracycline-inducible Kank-RNAi cells were generated 
  Figure 8.       A hypothetical model of RhoA 
regulation by Kank.   Growth factors such 
as insulin stimulate the PI3K  –  Akt signal. The 
14-3-3 complex then activates RhoA, which 
is located downstream of the PI3K  –  Akt signal 
or other signaling pathways. When cells need 
to negatively regulate the migration, Kank is 
phosphorylated by Akt and sequesters 14-3-3     
from the 14-3-3 complex, resulting in suppres-
sion of active RhoA. Hypothetical pathways 
are indicated by hatched arrows.     JCB • VOLUME 181 • NUMBER 3 • 2008  548
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cells and human cell lines. A 19-nucleotide sequence corresponding to 
nucleotides 609  –  627 (5    -GAGGCGAAAGCCATCTGTG-3    ) of a mouse 
cDNA clone, A530060J16 (GenBank/EMBL/DDBJ under accession No. 
  AK041011.1  ), was used for RNAi for mouse   Kank  , and a 19-nucleotide 
sequence corresponding to nucleotides 2,043  –  2,262 (5    -GTGACCGTCT-
GCTCTCCAA-3    ) of human   Kank   cDNA (GenBank/EMBL/DDBJ under 
accession No.   NM_015158  ) was used for RNAi for human   Kank  . 
  Kank  -esiRNA was prepared as described previously (  Kittler et al., 2004  ; 
  Yang et al., 2002  ). In brief, sense and antisense RNA was transcribed 
from human   Kank   plasmids using a T7 promoter system (for both strands) 
supplied in a MEGAscript kit (Ambion). After annealing the sense and anti-
sense strands, RNA was treated with ShortCut RNase III (New England Bio-
labs, Inc.) and puriﬁ  ed with Sepharose Q (GE Healthcare).   Kank   esiRNA 
and control esiRNA containing the   Xenopus laevis   elongation factor gene 
was transfected into HEK293 cells using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer  ’  s instructions. 
  In vitro binding assay 
  The coiled-coil domain of Kank and its mutant containing S167A were 
generated by using a TNT-coupled reticulocyte lysate system with biotinyl-
ated Lys-tRNA (Promega) and mixed with bacterially expressed GST-tagged 
14-3-3 isoforms. These protein complexes were pulled down with glutathi-
one  –  Sepharose 4B and subjected to SDS-PAGE followed by Western blot-
ting. The bands were detected using HRP-conjugated streptavidin. 
  In vitro phosphorylation assays 
  In vitro phosphorylation assays were performed using Akt/PKB protein 
kinase (Cell Signaling Technology) with [    - 
32  P]ATP according to the manu-
facturer  ’  s instructions. GST-GSK3     was used as a positive control for 
phosphorylation by Akt. 
  Immunocytochemistry 
  The cells grown on glass coverslips were washed three times with PBS and 
ﬁ  xed with 3.7% formaldehyde/PBS for 30 min at room temperature or 
cold methanol for 15 min at   –  20  °  C. After the cells were treated with 0.25% 
Triton X-100 for 10 min at room temperature, they were incubated with the 
appropriate antibodies. After washing with PBS, the cells were incubated 
with the indicated secondary antibodies. F-actin was stained using TRITC-
conjugated phalloidin (Sigma-Aldrich). Fluorochromes used are indicated 
in ﬁ  gure legends. Images of cells mounted at room temperature in 80% 
(wt/vol) glycerol in PBS were acquired with AxioVision 3.1 (Carl Zeiss, 
Inc.) using a ﬂ  uorescence microscope (Axioskop 2 plus; Carl Zeiss, Inc.) 
with a Plan-Neoﬂ  uar 40  ×   NA 0.75 objective (Carl Zeiss, Inc.) and a color 
camera (AxioCam HRc; Carl Zeiss, Inc.). Images were prepared with Photo  -
shop 7.0 (Adobe). 
  Cell migration assay 
  Cell migration assays were performed as described previously with some 
modiﬁ  cations (  Praus et al., 1999  ). In brief, transfection was performed 
using Lipofectamine 2000 (Invitrogen) 1 d before the assay. Tetracycline 
induction was started 24 h before the assay. TransWells (Corning Incor-
porated) were precoated with ECL cell attachment matrix before use and 
cells (5   ×   10 
4  ) were seeded in the upper chamber and incubated for 16 h. 
The cells were then ﬁ  xed and stained with Mayer  ’  s Hematoxylin (Wako 
Pure Chemical Industries, Ltd.). Migrated cells in 10 randomly chosen 
ﬁ  elds of each well were counted. Each experiment was performed at least 
three times. 
  GST-RBD pull-down assays 
  GST-RBD pull-down assays were performed as described previously (  Divi-
ani et al., 2004  ). In brief, the cells were lysed in ice-cold lysis buffer con-
taining 0.1% SDS. The cell lysates were centrifuged and the concentrations 
of protein in the supernatants were quantiﬁ  ed with a DC protein assay kit 
(Bio-Rad Laboratories). Equal amounts of proteins were pulled down with 
GST-RBD and glutathione  –  Sepharose 4B for 1 h at 4  °  C. The precipitates 
were washed ﬁ  ve times with the 0.1% SDS lysis buffer and subjected to 
Western blotting. The bands were quantiﬁ  ed using ImageQuant software 
(Molecular Dynamics). 
  Online supplemental material 
  Fig. S1 shows that Kank negatively regulates F-actin. Fig. S2 shows that 
Kank inhibits cell migration through 14-3-3 in HEK293 cells. Fig. S3 shows 
that Kank inhibits RhoA-dependent cell migration in HEK293 cells. Fig. S4 
shows that the interaction between Kank and IRSp53 is only slightly 
affected by 14-3-3. Online supplemental material is available at http://
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